YOLFTbeta
08

Vivozon Healthcare Inc

082800 · KQ · Healthcare / Pharmaceuticals

3,050.00KRW+65.00 (+2.18%)

Price History

Full chart

Market Stats

Previous Close2,985.00
Open3,000.00
Day Range2,955.00 – 3,070.00
52-Week Range2,070.00 – 6,430.00
Volume59.59K
Market Cap178.96B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.07
50-Day Avg2,842.50
200-Day Avg3,340.61

About

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED PAR lamps, LED bulb lamps, and home LED lightings. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon Pharmaceutical Co., Ltd. in November 2022. Vivozon Pharmaceutical Co., Ltd. was founded in 2002 and is based in Yongin, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Jin Soo Lee
  • Employees17
  • Headquarters64-1, Bongmu-ri, Yongin-Si, South Korea, Korea
  • Websitehttps://www.lumimicro.com

Leadership

  • Mr. Jin Soo LeeChief Exec. Officer
  • Eun-Soo AhnExec. Officer
  • Jung-Hyun YoonExec. Officer
  • Ho-Sik YounExec. Officer

Financials

Income Statement

Currency: KRW2009-12-312010-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue26.73B55.59B119.99B89.74B68.21B61.02B46.00B44.95B43.59B57.73B51.56B71.32B87.60B59.34B
Growth (%)-+107.96%+115.86%-25.21%-23.99%-10.54%-24.61%-2.28%-3.03%+32.43%-10.68%+38.31%+22.83%-32.26%
Cost of Revenue21.96B39.99B115.73B89.42B62.78B60.32B54.29B41.65B36.46B38.07B30.13B40.00B42.19B35.16B
Gross Profit--4.26B319.78M5.43B703.23M-8.28B3.30B7.13B19.66B21.44B31.32B45.41B24.18B
Gross Margin--3.55%0.36%7.96%1.15%-18.01%7.34%16.36%34.06%41.57%43.92%51.83%40.75%
Operating Expense--7.25B9.73B5.27B6.46B5.77B20.86B27.43B73.67B32.22B28.76B43.61B43.35B
Operating Income---2.98B-9.41B155.45M-5.75B-14.05B-17.56B-20.30B-54.01B-10.78B2.56B1.80B-19.17B
Operating Margin---2.49%-10.49%0.23%-9.43%-30.55%-39.06%-46.56%-93.55%-20.91%3.58%2.05%-32.30%
EBITDA-----------16.43B3.97B-4.72B-25.65B
EBITDA Margin-----------31.86%5.57%-5.39%-43.22%
Net Income---1.30B-9.70B-1.78B-6.67B-8.53B-28.00B-43.75B-69.46B-39.91B-3.36B-9.98B-32.42B
Net Income Margin---1.08%-10.81%-2.61%-10.93%-18.55%-62.28%-100.37%-120.31%-77.39%-4.71%-11.39%-54.64%
R&D--189.40M501.68M402.32M275.66M--2.87B3.94B2.31B2.54B3.57B3.33B
R&D as % of Total Revenue--0.16%0.56%0.59%0.45%--6.58%6.82%4.48%3.56%4.08%5.62%
Interest Expense0000000010.79B7.30B3.88B2.90B2.25B2.20B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%24.76%12.64%7.52%4.07%2.57%3.71%

Balance Sheet

Currency: KRW2009-12-312010-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets86.69B140.22B53.54B48.71B41.96B36.40B100.65B164.65B248.16B194.47B187.07B173.65B184.45B165.48B
Total Liabilities37.45B84.07B19.64B24.05B19.22B20.31B32.21B55.66B140.36B109.35B81.24B69.58B78.02B92.82B
Total Equity44.47B40.09B33.90B24.65B22.74B16.10B68.45B109.00B107.80B85.12B105.84B104.07B106.43B72.66B
Cash16.21B6.85B1.04B1.21B1.69B1.60B12.32B57.33B64.33B13.80B2.35B7.99B6.52B3.14B
Total Debt-------7.27M29.40B-----
Net Debt--------42.36B69.02B54.39B32.01B27.95B37.79B

Cash Flow

Currency: KRW2009-12-312010-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--3.03B2.78B5.87B-4.59B-4.59B-3.89B4.62B-17.50B-3.32B2.99B5.73B-6.87B
Investing Cash Flow---1.10B-4.24B-765.34M-56.89B-56.89B-35.63B-64.18B-47.13B-34.55B19.31B-6.37B-
Financing Cash Flow32.84B57.43B-8.67B1.62B-4.64B72.21B72.21B102.07B67.24B13.52B26.39B-16.66B-818.68M-
Capital Expenditure9.24B55.02B4.20B2.00B1.81B1.50B1.50B212.10M869.36M10.11B8.64B6.67B10.54B2.21B
Free Cash Flow--------3.43B-29.54B-11.97B-3.68B-4.81B-9.08B
FCF to OCF--------74.12%168.86%360.07%-122.96%-83.86%132.22%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 16, 2016Nov 11, 2016Jan 25, 2017May 12, 2017Aug 11, 2017Nov 14, 2017Mar 14, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------
EPS Actual-43.38-170.97-319.90-116.02262.86291.57-290.0370.12-202.91113.85-301.5339.06-62.02-201.0163.06-315.63-287.00-81.73-523.657.68-45.00-6.418.64-3.40-37.66-26.87-62.85-23.75-61.67-606.9599.70-42.92-53.6242.90-403.6035.62-73.71-1070.58-177.94-34.01-233.54-1487.54-237.49-154.14-119.46-328.53-39.73-3.524.80-28.32-19.58-10.355.06-171.76-71.82-80.17-220.95-242.64-106.60-47.07
Surprise------------------------------------------------------------
Timing--------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-------------------------------

Key Statistics & Ratios

Market Cap178.96B
Enterprise Value191.16B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.02
Price / Book1.77
Revenue (TTM)59.86B
Gross Profit (TTM)19.66B
EBITDA-18.45B
Profit Margin-126.73%
Operating Margin-37.72%
Return on Equity-1315.31%
Return on Assets-6.38%
Shares Outstanding74.46M
Shares Float139.73M
Beta0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jan 9, 2026939:883
  • Nov 10, 20231:5
  • Jun 28, 20131165:1119
  • Nov 2, 20091121:1048
  • May 7, 20091542:1375
  • Dec 27, 2006213:185